David W. Crabb

Overview

Best Publications

• Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men.

  Holly Read Thomasson;Howard J. Edenberg;David W. Crabb;Xiao Ling Mai

  758
  Citations

• Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant.

  D W Crabb;H J Edenberg;W F Bosron;T K Li

  683
  Citations

• Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases

  David W. Crabb;Gene Y. Im;Gyongyi Szabo;Jessica L. Mellinger

  667
  Citations

• Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP).

  Min You;Monika Fischer;Mark A. Deeg;David W. Crabb

  601
  Citations

• Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology

  David W. Crabb;Michinaga Matsumoto;David Chang;Min You

  587
  Citations

• Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

  Andrea Galli;David W. Crabb;Elisabetta Ceni;Renata Salzano

  545
  Citations

• Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia

  David W. Crabb;Ramon Bataller;Naga P. Chalasani;Patrick S. Kamath

  482
  Citations

• The role of AMP-activated protein kinase in the action of ethanol in the liver.

  Min You;Michinaga Matsumoto;Christine M. Pacold;Won Kyoo Cho

  478
  Citations

• Alcohol and Medication Interactions

  Ron Weathermon;David W. Crabb

  449
  Citations

• Systemic Levels of Lipid Peroxidation and Its Metabolic and Dietary Correlates in Patients with Nonalcoholic Steatohepatitis

  Naga Chalasani;Mark A Deeg;David W Crabb

  429
  Citations

• Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

  Naga Chalasani;J. Christopher Gorski;Maleeha S. Asghar;Ali Asghar

  427
  Citations

• Peroxisome Proliferator-activated Receptor α (PPARα) Agonist Treatment Reverses PPARα Dysfunction and Abnormalities in Hepatic Lipid Metabolism in Ethanol-fed Mice

  Monika Fischer;Min You;Michinaga Matsumoto;David W. Crabb

  328
  Citations

• Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.

  Min You;Robert V. Considine;Teresa C. Leone;Daniel P. Kelly

  318
  Citations

• The Transcriptional and DNA Binding Activity of Peroxisome Proliferator-activated Receptor α Is Inhibited by Ethanol Metabolism A NOVEL MECHANISM FOR THE DEVELOPMENT OF ETHANOL-INDUCED FATTY LIVER

  Andrea Galli;Jane Pinaire;Monika Fischer;Ryan Dorris

  284
  Citations

• Alcohol consumption and ethyl carbamate

  Naomi Allen;Lucy M. Anderson;Frederick A. Beland;Jacques Bénichou

  279
  Citations

• Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.

  Min You;David W. Crabb

  275
  Citations

• Alcohol and lipid metabolism.

  Margaret Sozio;David W. Crabb

  260
  Citations

• Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor–induced proliferation of human hepatic stellate cells

  Andrea Galli;David Crabb;Donna Price;Elisabetta Ceni

  252
  Citations

• Alcohol and aldehyde dehydrogenase polymorphisms and alcoholism

  Holly R. Thomasson;David W. Crabb;Howard J. Edenberg;Ting Kai Li

  227
  Citations

• Genotypes for Aldehyde Dehydrogenase Deficiency and Alcohol Sensitivity

  David W. Crabb;Howard J. Edenberg;William F. Bosron;Ting-Kai Li

  133
  Citations